1. Home
  2. WLY vs ENOV Comparison

WLY vs ENOV Comparison

Compare WLY & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • ENOV
  • Stock Information
  • Founded
  • WLY 1807
  • ENOV 1995
  • Country
  • WLY United States
  • ENOV United States
  • Employees
  • WLY N/A
  • ENOV N/A
  • Industry
  • WLY Books
  • ENOV Fluid Controls
  • Sector
  • WLY Consumer Discretionary
  • ENOV Industrials
  • Exchange
  • WLY Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • WLY 2.2B
  • ENOV 2.1B
  • IPO Year
  • WLY N/A
  • ENOV 2008
  • Fundamental
  • Price
  • WLY $44.43
  • ENOV $37.62
  • Analyst Decision
  • WLY
  • ENOV Buy
  • Analyst Count
  • WLY 0
  • ENOV 4
  • Target Price
  • WLY N/A
  • ENOV $58.50
  • AVG Volume (30 Days)
  • WLY 621.7K
  • ENOV 931.0K
  • Earning Date
  • WLY 03-06-2025
  • ENOV 05-01-2025
  • Dividend Yield
  • WLY 3.18%
  • ENOV N/A
  • EPS Growth
  • WLY N/A
  • ENOV N/A
  • EPS
  • WLY 0.75
  • ENOV N/A
  • Revenue
  • WLY $1,703,491,000.00
  • ENOV $2,107,623,000.00
  • Revenue This Year
  • WLY N/A
  • ENOV $7.09
  • Revenue Next Year
  • WLY $1.13
  • ENOV $6.38
  • P/E Ratio
  • WLY $59.11
  • ENOV N/A
  • Revenue Growth
  • WLY N/A
  • ENOV 23.45
  • 52 Week Low
  • WLY $34.85
  • ENOV $35.14
  • 52 Week High
  • WLY $53.96
  • ENOV $62.79
  • Technical
  • Relative Strength Index (RSI)
  • WLY 56.08
  • ENOV 42.34
  • Support Level
  • WLY $44.19
  • ENOV $38.51
  • Resistance Level
  • WLY $45.08
  • ENOV $40.70
  • Average True Range (ATR)
  • WLY 1.05
  • ENOV 1.29
  • MACD
  • WLY -0.02
  • ENOV 0.34
  • Stochastic Oscillator
  • WLY 31.25
  • ENOV 50.47

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: